Significance of myelosuppression in the chemotherapy of early breast cancer
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1006-9801.2020.02.016
   		
        
        	
        		- VernacularTitle:骨髓抑制在早期乳腺癌化疗过程中的意义
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Ying CHEN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Yifan ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Jinxiang ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Jiaqi WANG
			        		
			        		;
		        		
		        		
		        		
			        		Yi JIANG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 吉林大学第二医院乳腺外科,长春 130000
			        		
		        		
	        		
        		 
        	
        	
        	
        	
            
            
            	- From:
	            		
	            			Cancer Research and Clinic
	            		
	            		 2020;32(2):137-140
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Chemotherapy has become an important therapy for breast cancer. The myelosuppression is an inevitable adverse reaction during the chemotherapy, as well as a sign of drug effectiveness to some degree. Some retrospective studies have found that the patients with myelosuppression show the better survival in the chemotherapy of early breast cancer. This paper discusses the significance of myelosuppression in the chemotherapy of early breast cancer.